All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit Know GvHD.

  TRANSLATE

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The GVHD Hub is an independent medical education platform, sponsored by Medac and supported through independent educational grants from Incyte, Sanofi and Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

EHA 2023

Share:

Jun 8, 2023


X post image

6 Jun 2023

The @GvHD_Hub will be attending the #EHA2023 Congress on June 8–11.

Our team will be attending both online and in person in Frankfurt, Germany.

Keep an eye on our socials for live updates throughout the congress! 🗣💻

@EHA_Hematology #gvhd #bmtsm #hematology
X post image

2 Jun 2023

ABSTRACT S290 : Development and validation of a prognostic model of bronchiolitis obliterans syndrome in adult patients following allogeneic hematopoietic stem cell transplantation

#EHA2023 #GvHD
X post image

2 Jun 2023

ABSTRACT S245: Ruxolitinib in pediatric patients with treatment-naive or steroid-refractory chronic graft versus host disease: primary findings from the phase II Reach5 study

#EHA2023 #GvHD
X post image

2 Jun 2023

ABSTRACT S246: JAK/ROCK inhibitor tq05105 for glucocorticoid-refractory or -dependent chronic graft-versus-host disease: updated results of a phase 1b/2 study

#EHA2023 #GvHD
X post image

2 Jun 2023

ABSTRACT S243: Lactate produced by T cells during aGvHD promotes second signal generation for T cell activation through histone modification

#EHA2023 #GvHD
X post image

2 Jun 2023

ABSTRACT S242: Mast cells are mediators of inflammatory effector cell recruitment and fibrosis in dermal chronic graft-versus-host disease

#EHA2023 #GvHD
X post image

2 Jun 2023

ABSTRACT S240: Targeting PRMT1 alleviates chronic graft-versus-host disease by reducing T and B pathogenicity

#EHA2023 #GvHD
X post image

2 Jun 2023

ABSTRACT S241: Itaconate inhibits TH1 differentiation and acute graft-versus-host disease via NRF2

#EHA2023 #GvHD
X post image

2 Jun 2023

#EHA2023 | Check out our picks for the top abstracts in GvHD!

See our full selection in the thread below and let us know your thoughts! 👇

#GvHD #GvHDsm #BMTsm

<span>&nbsp;</span>

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content